On October 27 and 28, 2021, HGPI Chairman Dr. Kiyoshi Kurokawa and HGPI CEO and Board Member Mr. Ryoji Noritake spoke at various programs throughout both days of the 8th NIKKEI FT Communicable Diseases Conference, which was entitled “Never to Repeat the Crisis: Renewal of Our Commitment for Fighting against Communicable Diseases.” The event was co-hosted by the NIKKEI, the Financial Times and Tokyo Metropolitan Government.

For details, please visit the event website, which can be found here.

Below is an excerpt from the program that included Dr. Kurokawa and Mr. Noritake. The full speaker list can be viewed here.

October 27 (Wed.)

Special Session 1: Effectiveness of Antigen testing in the prevention of COVID-19 infectious diseases
 Discusser: Kiyoshi Kurokawa (HGPI Chairman)
 

Special Session 2: Collaboration among Stakeholders to Implement the “Strategy for Strengthening Vaccine Development and Production Systems”
 Moderator: Ryoji Noritake (HGPI Board Member and CEO)
 

Special Agenda: How International Consortium Accelerates Drug Development for COVID-19
 Discusser: Kiyoshi Kurokawa

October 28 (Thu.)

Agenda 7 – Key discussion issue 6: Nation’s decision making
 Discusser: Ryoji Noritake
 

Special Session 5: Urgent need for measures against AMR threat as silent pandemics
 Moderator: Ryoji Noritake

Breakout Session E: The economic value of AMR countermeasures and the need for new antimicrobials
 Moderator: Ryoji Noritake
 

Agenda 8 – PPP projects from the Conference and their future issues
 Moderator: Ryoji Noritake
 

Summary Session
 Discusser: Ryoji Noritake

Conclusion/Statement
 Discusser: Ryoji Noritake